Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
Blood · 12.01.2023 · 141 (2) · 194-199
DOI: 10.1182/blood.2022016218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 12.01.2023. Verfasst von Huihui Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Vascular Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Sickle cell disease (SCD) is an inherited disorder resulting from a β-globin gene mutation, and SCD patients experience erythrocyte sickling, vaso-occlusive episodes (VOE), and progressive organ damage. Chronic hemolysis, inflammation, and repeated red blood cell transfusions in SCD can disrupt iron homeostasis. Patients who receive multiple blood transfusions develop iron overload, and another subpopulation of SCD patients manifest iron deficiency. To elucidate connections between dietary iron, the microbiome, and SCD pathogenesis, we treated SCD mice with an iron-restricted diet (IRD). IRD treatment reduced iron availability and hemolysis, decreased acute VOE, and ameliorated chronic organ damage in SCD mice. Our results extend previous studies indicating that the gut microbiota regulate disease in SCD mice. IRD alters microbiota load and improves gut integrity, together preventing crosstalk between the gut microbiome and inflammatory factors such as aged neutrophils, dampening VOE, and organ damage. These findings provide strong evidence for the therapeutic potential of manipulating iron homeostasis and the gut microbiome to ameliorate SCD pathophysiology. Many treatments, which are under development, focus on lowering the systemic iron concentration to relieve disease complications, and our data suggest that iron-induced changes in microbiota load and gut integrity are related- and novel-therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY.
- Department of Systems and Computational Biology, Albert Einstein College of Medicine, Bronx, NY.
- Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY.
- The Tisch Cancer Institute, Division of Hematology and Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
- The Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY.
ORCID-Profile: Huihui Li, Dachuan Zhang, Xin Gao, Maria Maryanovich, Lidiane Torres, Divij Verma, Libusha Kelly, Yelena Z Ginzburg, Paul S Frenette, Deepa Manwani
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIH HHS
Zitieren
APA
Li, H., Kazmi, J. S., Lee, S., Zhang, D., Gao, X., Maryanovich, M., Torres, L., Verma, D., Kelly, L., Ginzburg, Y. Z., Frenette, P. S., & Manwani, D. (2023). Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease. Blood, 141(2), 194-199. https://doi.org/10.1182/blood.2022016218
Vancouver
Li H, Kazmi JS, Lee S, Zhang D, Gao X, Maryanovich M, et al. Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease. Blood. 2023;141(2):194-199. doi:10.1182/blood.2022016218
BibTeX
@article{Li2023,
author = {Li, Huihui and Kazmi, Jacob S and Lee, Sungkyun and Zhang, Dachuan and Gao, Xin and Maryanovich, Maria and Torres, Lidiane and Verma, Divij and Kelly, Libusha and Ginzburg, Yelena Z and Frenette, Paul S and Manwani, Deepa},
title = {Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease},
journal = {Blood},
year = {2023},
volume = {141},
number = {2},
pages = {194--199},
doi = {10.1182/blood.2022016218}
}
EUVIMED